These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18772698)

  • 1. National trends in hospital outcomes among patients with Guillain-Barré syndrome requiring mechanical ventilation.
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2008 Sep; 10(1):24-8. PubMed ID: 18772698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical ventilation in patients with Guillain-Barré syndrome.
    Ali MI; Fernández-Pérez ER; Pendem S; Brown DR; Wijdicks EF; Gajic O
    Respir Care; 2006 Dec; 51(12):1403-7. PubMed ID: 17134520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
    Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for Guillain-Barré syndrome in the US hospitals.
    Alshekhlee A; Hussain Z; Sultan B; Katirji B
    J Clin Neuromuscul Dis; 2008 Sep; 10(1):4-10. PubMed ID: 18772694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome: rehabilitation outcome and recent developments.
    Melillo EM; Sethi JM; Mohsenin V
    Yale J Biol Med; 1998; 71(5):383-9. PubMed ID: 10527365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of human immunodeficiency virus on intensive care unit outcome of patients with Guillain-Barré syndrome.
    Schleicher GK; Black A; Mochan A; Richards GA
    Crit Care Med; 2003 Jun; 31(6):1848-50. PubMed ID: 12794429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical ventilation in Guillain-Barré syndrome: does age influence functional outcome?
    Köhrmann M; Huttner HB; Nowe T; Schellinger PD; Schwab S
    Eur Neurol; 2009; 61(6):358-63. PubMed ID: 19365128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.
    Tsai CP; Wang KC; Liu CY; Sheng WY; Lee TC
    J Clin Neurosci; 2007 Jul; 14(7):625-9. PubMed ID: 17532498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of patients with Guillain-Barré syndrome requiring mechanical ventilation.
    Netto AB; Taly AB; Kulkarni GB; Uma Maheshwara Rao GS; Rao S
    Neurol India; 2011; 59(5):707-11. PubMed ID: 22019655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes for patients with Guillain-Barré syndrome requiring mechanical ventilation: a literature review.
    de Boisanger L
    Ir J Med Sci; 2016 Feb; 185(1):11-5. PubMed ID: 26443749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome.
    Sanjay R; Flanagan J; Sodano D; Gorson KC; Ropper AH; Weinstein R
    J Clin Apher; 2006 Jul; 21(2):105-10. PubMed ID: 16342192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal variation in the clinical recovery of patients with Guillain Barré syndrome requiring mechanical ventilation.
    Sriganesh K; Netto A; Kulkarni GB; Taly AB; Umamaheswara Rao GS
    Neurol India; 2013; 61(4):349-54. PubMed ID: 24005723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventilatory management of respiratory failure in patients with severe Guillain-Barre syndrome.
    Aggarwal AN; Gupta D; Lal V; Behera D; Jindal SK; Prabhakar S
    Neurol India; 2003 Jun; 51(2):203-5. PubMed ID: 14571003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Respiratory failure in the Guillain Barré syndrome].
    Schottlender JG; Lombardi D; Toledo A; Otero C; Mazia C; Menga G
    Medicina (B Aires); 1999; 59(6):705-9. PubMed ID: 10752212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome.
    Mehndiratta MM; Chowdhury D; Goel V
    J Assoc Physicians India; 2001 Apr; 49():459-69. PubMed ID: 11762620
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
    Ortiz-Corredor F; Peña-Preciado M
    Acta Neurol Scand; 2007 Apr; 115(4):289-93. PubMed ID: 17376129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical and electrophysiologic survey of childhood Guillain-Barré syndrome.
    Hung PL; Chang WN; Huang LT; Huang SC; Chang YC; Chang CJ; Chang CS; Wang KW; Cheng BC; Chang HW; Lu CH
    Pediatr Neurol; 2004 Feb; 30(2):86-91. PubMed ID: 14984898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasmapheresis in Guillain-Barre syndrome].
    Carbajal-Ramírez A; Castañón-González JA; Osvaldo-Talavera J; de la Torre-Nieto ML; León-Gutiérrez MA
    Gac Med Mex; 2002; 138(6):527-31. PubMed ID: 12532617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.